Title: Physician, Medical Educator and Biomedical Scientist
Location: Nashville, Tennessee, United States
John A. Oates, MD, Physician, Medical Educator and Biomedical Scientist, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in hypertension.
Committed to providing top patient care in the Nashville, Tennessee, area, Dr. Oates is highly regarded as an expert physician in the care of conditions of the heart, specifically in persistently elevated blood pressure. His top achievements in the field include his co-discovery of the antihypertensive effect of methyldopa. He has conducted extensive research in biochemistry, pharmacology and pathophysiology of Eicosanoids. Additionally, Dr. Oates is noted for his work in the elucidation of interactions between drugs in humans. For his tremendous impact on the medical community in his career, Dr. Oates earned an Earl Sutherland Award for Achievement in Research, a Novartis Award Council for High Blood Pressure Research, an Award of Excellence in Clinical Research from The General Clinical Research Centers Program at the National Institutes of Health, a Distinguished Achievement Award from the New York Hospital-Cornell Medical Center, an Award of Merit from the American Heart Association, and an Oscar B. Hunter Award from the American Society for Clinical Pharmacology and Therapeutics, among many others. The factors or attributes that Dr. Oates feel have played a role in his success besides knowledge, expertise, and experience is his love for working with patients and students. His career achievements have been supported by his education, which includes an MD from the Bowman Gray School of Medicine at Wake Forest College, as well as a Bachelor of Science from the same university. Dr. Oates is board certified in the subspecialty of hypertension and he is a diplomate of the American Board of Internal Medicine.
Today, Dr. Oates excels as a Thomas F. Frist Senior Professor of Medicine at Vanderbilt University School of Medicine. He has been distinguished in this role since 1988; however, his tenure with the university dates back to 1963. His noteworthy positions within the academic institution include professor of medicine and pharmacology, chairman of the department of medicine, and Joe and Morris Werthan professor of investigative medicine. Dr. Oates has also had an impact in projects outside of his full-time work. He was a member of the advisory council for the National Heart, Lung and Blood Institute, chairman of the pharmacology and toxicology training committee for the National Institute of General Medical Sciences, and member of the drug research board for the National Academy of Sciences. Additionally, he was a scientific advisor for the Board of Cumberland Pharmaceuticals and co-authored many publications. His most recent articles include “Triamterene Enhances the Blood Pressure Lowering Effect of Hydrochlorothiazide in Patients with Hypertension” in the Journal of General Internal Medicine, “Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor-Deficient Mice” and “Introduction: Misoprostol and Eicosanoid Symposium.” In looking ahead to the future, Dr. Oates intends to continue providing excellent work in his current role while taking on new opportunities to further impact the medical field.
Contact Dr. Oates: